Q3 FY26 Revenue Growth Hits 15.9% as UiPath Sees First GAAP Profitability Path
UiPath’s Q3 FY26 revenue growth re-accelerated to 15.9%, and the company has raised its full-year guidance, projecting first-time GAAP profitability in FY26. Its unified RPA and agentic AI platform, including Maestro orchestration, expands automation scope and potential revenue, while direct AI monetization remains nascent.
1. Operational Turnaround Fuels 53.6% Share Gain
Since a buy recommendation on March 7, 2025, UiPath’s share performance has outpaced the S&P 500 with a 53.6% total return through January 7, 2026. This rally reflects sustained execution on cost controls and sales efficiency initiatives launched in early FY25, which drove a reduction in operating cash burn by over 40% year-over-year and improved billings productivity by 25%. Customer retention rates have climbed to 92%, underscoring the effectiveness of UiPath’s go-to-market and services investments.
2. Revenue Re-Acceleration and Upgraded Profitability Outlook
In Q3 FY26, UiPath reported revenue growth of 15.9% year-over-year, up from 12.3% in the prior quarter. The company raised full-year guidance for subscription and support revenues by $25 million at the midpoint, now targeting $1.22 billion to $1.24 billion. Management reiterated its goal of achieving first-time GAAP profitability by the end of FY26, forecasting a non-GAAP operating margin of 5% to 7% and expecting free cash flow conversion above 80%.
3. Unified Automation Platform Broadens Market Reach
UiPath’s integration of core robotic process automation with agentic AI capabilities, orchestrated through its Maestro module, is designed to expand automation use cases beyond rule-based tasks into decision-centric workflows. With over 1,200 customers deploying AI-driven automations in pilot or production, the company estimates an incremental revenue opportunity of $3.5 billion from upsells and new licenses over the next three years. While direct monetization of agentic AI features remains in its early stages, cross-sell success within the existing $1.8 billion ARR base—split evenly between domestic and international markets—provides visibility on adoption curves.